Errors in Figure 2

In the Original Investigation titled “Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: the STOP-PASC Randomized Clinical Trial,”¹ published online on June 7, 2024, in JAMA Internal Medicine, the dashed lines to indicate 15 days and 10 weeks were not properly aligned with the x-axis labels. This article was corrected online.